• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Nicholas Robert Outlines How Patients Can Provide More Information on Newly Approved Drugs

Video

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses how patient-reported outcomes collected through real-world data can provide confirmatory information on newly approved drugs.

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses how patient-reported outcomes collected through real-world data can provide confirmatory information on newly approved drugs.

Transcript

How does real-world data’s incorporation of the patient perspective allow for confirmatory information regarding newly approved drugs?

One of things I think real-world evidence does is that it provides confirmatory information in terms of new treatments, but also it provides the opportunity to collect the perspective of what the patient is going through. So, something that is very exciting is so-called patient-reported outcomes, and we’re developing the capacity with our EMR [electronic medical record], that not only can we describe how the patient did, talk about their response, progression, their improvement, but also we can collect their impression of how their treatment, how they’re feeling, are they have side effects? And this is coincidental with the interests and the appreciation that the better you can follow your patients, the better your patients have an opportunity to communicate with their providers, the better care is achieved. This is again a situation where incentives are aligned. At the end of the day, better improving patient care and also you can collect information as outcomes researchers to be able to share that information with others.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.